Summary
  • Multi-target molecules 315
  • Clinical molecules 0
  • Avg pChEMBL 7.76
Top Co-occurrence Targets
Active Molecules (315)
InChIKey pChEMBL Type Targets Clinical
DULIAOKIHPSTBZ 10.0 Ki 3
JDMPXCANLSMISU 10.0 Ki 3
SMGNMBKPAWFKGH 10.0 Ki 3
VOMDFEZIJGRATE 10.0 Ki 3
FEBJFCFXFXZCLS 9.7 Ki 3
YCYCBCSJYGZXLL 9.6 IC50 3
CFMGTKRBVVZVBF 9.3 IC50 4
PFORZALCOLIZSP 9.3 Ki 3
IQKDRVURUHCSRA 9.2 IC50 4
KRVBPGRPHRGDBE 9.2 IC50 4
XXXWQTLZEUCJPJ 9.1 IC50 3
AGVSXXLDLPSANO 9.1 Ki 3
LOYIQGBTNJFCIL 9.1 IC50 4
IHPQWLFEUQBMFZ 9.1 IC50 4
KNQHCQDUNTWSPH 9.1 IC50 4
NWFWLEAQCNXLAB 9.0 IC50 4
NWNRFJLJFPUJSR 9.0 IC50 4
OIHIJLNMNDCCIY 9.0 IC50 4
RZCUJQGMLLHXFG 9.0 IC50 4
WFXFHGMKTRFARM 9.0 IC50 4
YHJYFWRWHAHNQA 9.0 IC50 4
XLLUDKOBZFHIKN 8.9 IC50 4
XFYOTNPRWVBFPP 8.9 IC50 4
MOJHZLPPVIASCY 8.8 IC50 4
NLCBQIDOYIYGHS 8.8 IC50 4
VXDRIGYTIFAUHJ 8.8 IC50 4
YNYFVDOGUKBANE 8.8 IC50 4
AMWXBFDFQCGDLH 8.8 IC50 4
GNMJIFOVLJTJGQ 8.8 IC50 4
LRSKPOKZPAQFRH 8.8 IC50 4
VCYVRAYCTRSTDK 8.8 IC50 4
NMFUHYFGDLXDAP 8.8 IC50 3
WXGVQUUZCZFRQM 8.8 IC50 4
CYWKRSLNXIMRQO 8.7 IC50 4
VMEBZEMJNJSXPG 8.7 IC50 3
DBKVPPPOBUUZEG 8.7 IC50 4
GZPOQDPGYRPDKE 8.7 IC50 4
ILEXPDKMDMRQKR 8.7 IC50 4
OPNNEDOKBVIBDQ 8.7 IC50 4
RHEVGRYWYIGWAV 8.7 IC50 4
SXFOFKRRPNGFMD 8.7 IC50 3
SYHBIJWOUCBHHI 8.7 Ki 2
WFXFHGMKTRFARM 8.7 IC50 4
XONCCNBWLVICPL 8.7 IC50 4
XONCCNBWLVICPL 8.6 IC50 4
XRACUQUEKFCAJG 8.6 IC50 3
LTXGWCYRWMVHSW 8.6 IC50 4
CMGPWMKFYBSJKI 8.6 IC50 4
GGGMJNVXWGTZHR 8.6 IC50 4
HFIAXUYJXXCQEM 8.6 IC50 4
2D structure